BRIGHTON JONES LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 151 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.

Quarter-by-quarter ownership
BRIGHTON JONES LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$20,520
-16.3%
19,0000.0%0.00%0.0%
Q2 2023$24,510
-2.3%
19,0000.0%0.00%0.0%
Q1 2023$25,080
-12.0%
19,0000.0%0.00%
-50.0%
Q4 2022$28,500
+29.5%
19,0000.0%0.00%
+100.0%
Q3 2022$22,000
+4.8%
19,0000.0%0.00%0.0%
Q2 2022$21,000
-63.8%
19,000
-2.6%
0.00%
-66.7%
Q1 2022$58,000
+13.7%
19,504
+0.5%
0.00%
+50.0%
Q4 2021$51,000
-27.1%
19,3980.0%0.00%
-50.0%
Q3 2021$70,000
-16.7%
19,3980.0%0.00%0.0%
Q2 2021$84,000
+27.3%
19,3980.0%0.00%0.0%
Q1 2021$66,000
-2.9%
19,3980.0%0.00%0.0%
Q4 2020$68,000
+47.8%
19,398
+2.1%
0.00%
+33.3%
Q3 2020$46,000
+31.4%
19,0000.0%0.00%0.0%
Q2 2020$35,000
+16.7%
19,0000.0%0.00%0.0%
Q1 2020$30,000
-23.1%
19,000
+5.6%
0.00%
-25.0%
Q4 2019$39,000
+14.7%
18,0000.0%0.00%0.0%
Q3 2019$34,00018,0000.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders